z-logo
open-access-imgOpen Access
ECG Markers of Cardiovascular Toxicity in Adult and Pediatric Cancer Treatment
Author(s) -
Ștefan Spînu,
Gabriel Cismaru,
Paul-Mihai Boarescu,
Sabina Istrătoaie,
Alina Gabriela Negru,
Cecilia Lazea,
Simona Căinap,
Daniela Iacob,
Alin Grosu,
George Săraci,
Claudia Burz,
Cosmin Andrei Cismaru
Publication year - 2021
Publication title -
disease markers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 66
eISSN - 1875-8630
pISSN - 0278-0240
DOI - 10.1155/2021/6653971
Subject(s) - cardiotoxicity , medicine , subclinical infection , chemotherapy , cardiology , electrocardiography , cardiac monitoring , cardiac toxicity , coronary angiography , cancer , cardiac tumors , radiology , myocardial infarction
When a cardiologist is asked to evaluate the cardiac toxic effects of chemotherapy, he/she can use several tools: ECG, echocardiography, coronary angiography, ventriculography, and cardiac MRI. Of all these, the fastest and easiest to use is the ECG, which can provide information on the occurrence of cardiac toxic effects and can show early signs of subclinical cardiac damage. These warning signs are the most desired to be recognized by the cardiologist, because the dose of chemotherapeutics can be adjusted so that the clinical side effects do not occur, or the therapy can be stopped in time, before irreversible side effects. This review addresses the problem of early detection of cardiotoxicity in adult and pediatric cancer treatment, by using simple ECG recordings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom